在研项目：
【1】.辽宁省自然基金20170540279 雷帕霉素治疗多囊肾病的耐药机制研究2017.5.1-2019.4.30 5万 【2】 2019.1.1-2020。12.31大连市创新基金 2019J13SN116 基于脱细胞衍生肺支架建立新型3D培养多囊肾细胞模型及细胞极性调控研究--刘春艳 10万收起
代表文章：
1. Liu CY, Zhang Y, Yuan L, Fu Lili and Mei CL. Rosiglitazone inhitibs insulin like growth factor 1 induced polycystic kidney disease cell growth and p70S6Kinase activation. Molecular Medicine Reports, 2013,8(3):861-864. IF: 1.557 2. Chunyan Liu, Hongdong Li, Xiang Gao, Ming Yang,Li Yuan, Lili Fu, Xueqi Wang, Changlin Mei. Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: A study of the mechanism of action. Americal Journal of renal physiology 2018 May 1;314(5):F844-F854 IF 3.612) 3 .Liu CY, Zhou LL, Cheng Q, Jiang SN, Sheng J, Sun JD, Zhao JY. Effect of bradykinin on renal mesangial cell proliferation and extracellular matrix secretion.Genetics and molecular research. 2014, 13 (1): 490-498 IF 0.775(第一作者) 4. Wang Y, Li YM, Zhang S, Zhao JY, Liu CY. zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy. Journal of International Medical Research 2016 Feb 8. (Epub ahead of print]) IF 1.438（通讯作者） 5.Wang Y, Zhou Y, Liu CY.A rare case of nutcracker phenomenon with Nephrotic syndrome，Int Urol Nephrol，2015 Nov 20 IF 1.292
